{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-003085","form_type":"8-K","ticker":"ASTC","cik":"0001001907","company_name":"ASTROTECH Corp","filed_at":"2023-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.402443+00:00","generated_at":"2026-06-19T15:17:02.202554+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Astrotech Q2 FY2023: $46.8M cash, YTD rev $301K, gross margin 38%, new products, $1M buyback","bullets":["YTD revenue $301K (6mo ended Dec 31, 2022); gross margin improved to 38% from 18% YoY.","Cash and liquid investments $46.8M; board authorized $1M share repurchase program on Nov 17, 2022.","Launched AgLAB 1000-D2 and D2-MVP control system; claims up to 45% improvement in yields and revenues.","BreathTest-1000 can distinguish infected vs healthy breath samples; collecting data for FDA approval.","Appointed Bob McFarland to board Jan 27, 2023; completed reverse stock split to regain Nasdaq compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-003085","json":"https://secwatch.observer/filing/0001437749-23-003085.json","markdown":"https://secwatch.observer/filing/0001437749-23-003085.md","text":"https://secwatch.observer/filing/0001437749-23-003085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001907/000143774923003085/0001437749-23-003085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001907/000143774923003085/astc20230210_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T15:17:02.202554+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4d7f1539aca45321f83b04e57103a056c515c574","claim":"ASTROTECH Corp reported second quarter of fiscal year 2023, which ended December 31, 2022 results: revenue Year-to-date revenue totaled $301 thousand.","evidence_excerpt":"Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for its second quarter of fiscal year 2023, which ended December 31, 2022. Financial Highlights & Recent Developments ● Astrotech’s consolidated balance sheet remains strong with $46.8 million in cash and liquid investments. ● Year-to-date revenue totaled $301 thousand","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1001907/000143774923003085/0001437749-23-003085-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter of fiscal year 2023, which ended December 31, 2022"},{"label":"Revenue","value":"Year-to-date revenue totaled $301 thousand"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}